IBSA sa Revenue and Competitors

USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • IBSA sa's estimated annual revenue is currently $228.3M per year.(i)
  • IBSA sa's estimated revenue per employee is $219,343

Employee Data

  • IBSA sa has 1041 Employees.(i)
  • IBSA sa grew their employee count by 11% last year.

IBSA sa's People

NameTitleEmail/Phone
1
Chief Technical Operations IBSA GroupReveal Email/Phone
2
Accounting Officer Finance & AdministrationReveal Email/Phone
3
Drug Safety OfficerReveal Email/Phone
4
Head Regulatory AffairsReveal Email/Phone
5
Accounting OfficerReveal Email/Phone
6
Apprendista IT Client Support OfficerReveal Email/Phone
7
Head Quality AssuranceReveal Email/Phone
8
Sr Accounts Payable OfficerReveal Email/Phone
9
Indirect Procurement OfficerReveal Email/Phone
10
Apprentice IT Client Support OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M22116%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M91-10%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M16-6%$114.3MN/A
#8
$7.2M28-7%N/AN/A
#9
$13.7M51-9%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is IBSA sa?

IBSA Institut Biochimique SA is a privately owned pharmaceutical company founded in Lugano in 1945. It started to develop its specific identity in 1985, when the current management took over, redefining its strategy and focusing on developing technologies that improve the quality of existing therapeutic solutions. Today, it is present on 5 continents and over 80 countries, including the USA. The Group now counts on 13 companies, subsidiaries and representative offices in Europe, China and USA, and boasts a product portfolio covering 10 major therapeutic areas. The company employs a total of 2,000 people, distributed among its headquarters, branches and manufacturing sites. IBSA is the largest privately owned pharmaceutical company in Switzerland, the fourth largest operator in the Fertility sector, after the major multinationals, and one of the world leaders in products based on hyaluronic acid. Therapeutic areas: Cardiovascular, Dermatology, Dermoaesthetic, Endocrinology, Human Reproduction, Respiratory, Rheumatology, Pain and Inflammation, Urology, Consumer Health.

keywords:N/A

N/A

Total Funding

1041

Number of Employees

$228.3M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

IBSA sa News

2022-04-20 - Global Non-opioid Analgesic Patch Market Executive ...

IBSA Institut Biochimque SA. Market segment by product type: Lidocaine Patches; Diclofenac Patches; Methyl Salicylate Patches; Capsaicin Patches; Ketoprofen...

2022-04-20 - synthetic Hormones Market is rapidly expanding due to the ...

... Inc., Endo Pharmaceuticals Inc., IBSA Institute Biochimique SA, Acerus Pharmaceuticals Corporation, and Lupin Pharmaceuticals, Inc.

2022-04-20 - Mana Murtii US: Leenjisaan kun tapha booda dirree keessatti kadhanaa gaggeessuu isaatiif adabamuu qabaturee?

... mana murtichaa sagal himata bitaa miraa dhiyaate sa'a lamaa oliif ilaalaniiru. ... dhaabbachuun falmaa ture ibsa miiddiyaaf kennee ture.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$299.4M10416%N/A
#2
$378.5M104217%N/A
#3
$393.9M10420%N/A
#4
$407.5M104213%N/A
#5
$407.5M104213%N/A